FDA.reportPublic FDA data

Application 205523

Type
ANDA
Sponsor
AJANTA PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ALMOTRIPTAN MALATEALMOTRIPTAN MALATETABLET;ORALEQ 6.25MG BASENoNo
002ALMOTRIPTAN MALATEALMOTRIPTAN MALATETABLET;ORALEQ 12.5MG BASENoYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
27241-041almotriptanalmotriptanAjanta Pharma USA Inc.ANDACurrent
27241-041almotriptanalmotriptanAjanta Pharma LimitedANDACurrent
27241-041almotriptanalmotriptanAjanta Pharma LimitedANDACurrent
27241-041almotriptanalmotriptanAjanta Pharma LimitedANDACurrent
27241-042almotriptanalmotriptanAjanta Pharma USA Inc.ANDACurrent
27241-042almotriptanalmotriptanAjanta Pharma LimitedANDACurrent
27241-042almotriptanalmotriptanAjanta Pharma LimitedANDACurrent
27241-042almotriptanalmotriptanAjanta Pharma LimitedANDACurrent